Listed below are the individual questions.
These links are handy when you want to see a specific question answered.
These links are handy when you want to see a specific question answered.
- A few years ago the device was already on the market - what happened to it?
- What have you learned from the past few years up until now?
- Were you expecting those with hyperacusis to respond better to the treatment?
- Is the treatment more effective on tinnitus, hyperacusis, or both?
- Did you distinguish between pain hyperacusis and sound intolerance hyperacusis?
- What is the safety profile for hyperacusis patients like?
- How does the device work and is it individually calibrated?
- Is there any need for re-calibration of the device, and if so, in what circumstances?
- Can the device be used at home, and what initial steps are required?
- What makes the device effective? Is it based on neuroplasticity?
- Is the treatment personalized to the individual's tinnitus?
- Does the tinnitus frequency or type of sound matter in terms of the treatment's efficacy?
- How does it actually help tinnitus? Does it reduce the loudness of tinnitus?
- Are you going to further follow up on the clinical trial participants?
- Can the device be used for more than one treatment period? Can it help with future tinnitus spikes?
- What was the level of improvement the trial participants experienced?
- Are there any groups of people who might not respond well to the treatment?
- Does the degree of hyperacusis matter in terms of benefiting from the treatment?
- Are you going to look deeper into subtyping of tinnitus?
- What is the timeline of the TENT-2 clinical trial?
- Are there any instances of tinnitus getting worse or being cured from the treatment?
- What is the general safety profile of the device?
- Do you have to have a certain level of hearing to qualify for the treatment?
- Is there any risk to using headphones for the duration of the treatment?
- Could the sound part of the treatment be delivered via hearing aids or earbuds in the future?
- Why did you choose TFI and THI as outcome measures in your clinical trials?
- Was the group of people with severe tinnitus represented in the clinical trials?
- Are you able to see how the treatment works? Do you have any brain imaging data?
- What is the science behind stimulating the tongue?
- Have you confirmed the safety of stimulating the tongue?
- Why did you choose audio as a form of stimulation?
- Have you gathered any data on how the treatment works on children?
- When will the device be released and where will it be available?
- Are there any estimations on how much the device will cost?
- Will the device need to be fitted by an audiologist?
- Are you training audiologists for the fitting of the device?
- Can people from other countries travel to Ireland to buy and get set up with the device?
- When will the device be available in the United States?
- Will the device be available via public health care or insurance plans?
- Outside of tongue stimulation, could the treatment be delivered on a smartphone?
- Are you accepting new investors?
- Does Neuromod have any financial relation to Tinnitus Talk?
- How competitive is the market place for tinnitus treatments?
- Who do you see as your competition in the market place?
- BONUS! Steve tests a demo unit of the device
- Parting thoughts and the value of Tinnitus Talk